-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B3vDwoWPe5ZcNvXYxy95UNyR5/Ktwh5Z+ARN4mfY3Z7l7p+nNpQYymmCOk8rJiDQ AyxR9f9zwFTXvZgVJYD56Q== /in/edgar/work/20000719/0000927016-00-002508/0000927016-00-002508.txt : 20000920 0000927016-00-002508.hdr.sgml : 20000920 ACCESSION NUMBER: 0000927016-00-002508 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20000718 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 20000719 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NMT MEDICAL INC CENTRAL INDEX KEY: 0001017259 STANDARD INDUSTRIAL CLASSIFICATION: [3841 ] IRS NUMBER: 954090463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-21001 FILM NUMBER: 675202 BUSINESS ADDRESS: STREET 1: 27 WORMWOOD STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6177370930 MAIL ADDRESS: STREET 1: 27 WORMWOOD STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: NITINOL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19960619 8-K 1 0001.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 18, 2000 NMT Medical, Inc. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in charter) Delaware 000-21001 95-4090463 - -------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer diction of incorporation) File Number) Identification No.) 27 Wormwood Street, Boston, Massachusetts 02210 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (617) 737-0930 N/A - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Item 5. Other Events. ------------ On July 18, 2000, NMT Medical, Inc. (the "Company") issued a press release announcing that the Board of Directors of the Company has restructured the interim management team so as to allow the Office of the President to have more of the day-to-day operating responsibilities. Accordingly, Jeffrey R. Jay, M.D., the Chairman of the Board, and R. John Fletcher, a member of the Board, have each resigned as Acting Co-Chief Executive Officer. William J. Knight, Vice President of Finance and Administration and Chief Financial Officer, and Rudy Davis, Vice President of Sales and Marketing, will each continue to serve as Acting Co-President. The full text of the Company's press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. ------------------------------------------------------------------ (c) Exhibits Exhibit No. Description - ----------- ----------- 99.1 Press Release, dated July 18, 2000, announcing the restructuring of the interim management team of NMT Medical, Inc. -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 19, 2000 NMT Medical, Inc. ----------------- (Registrant) By: /s/ Randall W. Davis ----------------------------- Name: Randall W. Davis Title: Acting Co-President -3- EXHIBIT INDEX Exhibit No. Description - ----------- ----------- 99.1 Press Release, dated July 18, 2000, announcing the restructuring of the interim management team of NMT Medical, Inc. EX-99.1 2 0002.txt PRESS RELEASE Exhibit 99.1 NMT MEDICAL, INC. 27 Wormwood Street BOSTON, MA 02210-1625 (NASDAQ/NMS:NMTI) AT THE COMPANY AT THE FINANCIAL RELATIONS BOARD - ------------------------- -------------------------------- William J. Knight General Info: Stuart Levine Chief Financial Officer Analyst Info: Brian Gill (617) 737-0930 Media Info: Deanne Eagle (212) 661-8030 NMT MEDICAL STREAMLINES ------------------------- ITS INTERIM MANAGEMENT TEAM --------------------------- BOSTON, MA, JULY 18, 2000 -- NMT Medical (Nasdaq/NMS:NMTI) today announced its decision to restructure the interim management team, allowing day-to-day operating responsibilities to be more focused into the Office of the President. To this end, Jeffrey R. Jay, M.D., Chairman of the NMT Board, and John Fletcher, an NMT Director, have decided to conclude their temporary assignments as Acting co-CEOs while retaining their roles on the Company's Board of Directors. In turn, Mr. William J. Knight, Vice President of Finance and CFO of NMT, and Mr. Rudy Davis, Vice President of Sales and Marketing, will continue to share responsibilities as Acting co-Presidents, positions they have held since May of this year. NMT Medical designs, develops and markets innovative medical devices that utilize advanced technologies and are delivered by minimally invasive procedures. The Company's products are designed to offer alternative approaches to existing complex treatments, thereby reducing patient trauma, shortening procedure, hospitalization and recovery times, and lowering overall treatment costs. The Company's medical devices include self-expanding stents, vena cava filters and septal repair devices. The NMT Neurosciences division serves the needs of neurosurgeons with a range of implantable and disposable products, including cerebral spinal fluid shunts, external drainage products, and the Spetzler(TM) Titanium Aneurysm Clip. This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties or other factors which may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed under the heading "Certain Factors That May Affect Future Results" included in the Management's Discussion and Analysis of Financial Conditions and Results of Operations in the Company's Annual Report on Form 10-K for the year ended December 31, 1999 and subsequent filings with the Securities and Exchange Commission. # # # To receive NMT Medical's latest news release and other corporate documents via FAX -- at no cost -- please dial 1-800-PRO-INFO. Enter the Company's symbol NMTI. -----END PRIVACY-ENHANCED MESSAGE-----